Literature DB >> 429265

The mechanism of decrease in nucleolar RNA synthesis by protein synthesis inhibition.

Y Mishima, T Matsui, M Muramatsu.   

Abstract

When protein biosynthesis is inhibited by either cycloheximide of puromycine, the nucleolar RNA synthesis of Ehrlich ascites tumor cells decreases by approximately 70% within 1 h, while the removal of these protein synthesis inhibitors causes a rapid recovery of nucleolar RNA synthesis, largely within 1 h. A similar pattern of decrease and recovery of endogenous RNA polymerase activity in isolated nucleoli or in nuclei (in the presence of alpha-amanitin) may be demonstrated after addition and removal of these drugs. Analysis of the molecular species of RNA polymerase I on a phosphocellulose column indicates that only the IB form of the enzyme decreases in the nucleoli of drug-treated cells and recovers quickly after resumption of protein synthesis. The finding that the activity of the IB form enzyme remains unchanged in the whole nuclei indicates that during cessation of protein synthesis RNA polymerase IB is either released from the nucleoli into the extranucleolar compartment or becomes so loosely bound to the nucleoli that it is leached out from the nucleoli during their isolation. By using a system of assaying free, nucleolar-template bound and total RNA polymerase I activities, data supporting the above interpretation have been obtained. Namely, in isolated nuclei free enzyme activity increases with a concomitant decrease in bound enzyme activity during protein synthesis inhibition, while the total enzyme activity remains unchanged. In isolated nucleoli, both total and bound enzyme activities decreases on protein synthesis inhibition but recover quickly on its resumption. The putative bound enzyme, fractionated with the aid of actinomycin D, is exclusively IB form, whereas the unbound enzyme consists of both IA and IB forms as previously demonstrated (1). No conversion of IB form polymerase to IA form was noted on prolonged sonication in our system. The levels of ATP and GTP in the cell did not change appreciably either during cessation or resumption of protein synthesis in these cells. The data support the previous conclusion that some short-lived protein(s) is required to maintain the normal level of ribosomal RNA transcription (2) and further suggest that the protein is required to facilitate reinitiation of the transcription by RNA polymerase IB in the nucleolus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429265

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  13 in total

1.  Inhibition of rRNA synthesis by poliovirus: specific inactivation of transcription factors.

Authors:  S J Rubinstein; A Dasgupta
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

2.  The nucleotide sequence of the putative transcription initiation site of a cloned ribosomal RNA gene of the mouse.

Authors:  Y Urano; R Kominami; Y Mishima; M Muramatsu
Journal:  Nucleic Acids Res       Date:  1980-12-20       Impact factor: 16.971

3.  A model for regulation of mammalian ribosomal DNA transcription. Co-ordination of initiation and termination.

Authors:  M Nashimoto; Y Mishima
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

4.  The RNA polymerase I-specific transcription initiation factor UBF is associated with transcriptionally active and inactive ribosomal genes.

Authors:  O V Zatsepina; R Voit; I Grummt; H Spring; M V Semenov; M F Trendelenburg
Journal:  Chromosoma       Date:  1993-11       Impact factor: 4.316

5.  In vitro transcription of a cloned mouse ribosomal RNA gene.

Authors:  Y Mishima; O Yamamoto; R Kominami; M Muramatsu
Journal:  Nucleic Acids Res       Date:  1981-12-21       Impact factor: 16.971

6.  Recruitment of TATA-binding protein-TAFI complex SL1 to the human ribosomal DNA promoter is mediated by the carboxy-terminal activation domain of upstream binding factor (UBF) and is regulated by UBF phosphorylation.

Authors:  J C Tuan; W Zhai; L Comai
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  Characterization of a factor that can prevent random transcription of cloned rDNA and its probable relationship to poly(ADP-ribose) polymerase.

Authors:  R N Kurl; S T Jacob
Journal:  Nucleic Acids Res       Date:  1985-01-11       Impact factor: 16.971

8.  RNA polymerase I associated factor 53 binds to the nucleolar transcription factor UBF and functions in specific rDNA transcription.

Authors:  K Hanada; C Z Song; K Yamamoto; K Yano; Y Maeda; K Yamaguchi; M Muramatsu
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

9.  Effects of glucocorticoid and cycloheximide on the activity and amount of RNA polymerase I in nuclei of rat liver.

Authors:  H Matsui; H Yazawa; N Suzuki; T Hosoya
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

10.  Fractionation and reconstitution of factors required for accurate transcription of mammalian ribosomal RNA genes: identification of a species-dependent initiation factor.

Authors:  Y Mishima; I Financsek; R Kominami; M Muramatsu
Journal:  Nucleic Acids Res       Date:  1982-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.